Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.45 Million shares of MRNA, which is worth approximately $36 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 316 shares (Common Stock) at a price of $25.98 per share, resulting in proceeds of $8,209. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M

0.1% 3M change

0.76% 12M change

Total Value Held $36 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Payment of exercise price or tax liability	$8,209 $25.98 p/Share	316 Reduced 0.02%	1,454,905 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	652 Added 0.04%	1,455,221 Common Stock
Nov 28 2025	SELL Payment of exercise price or tax liability	$7,377 $25.01 p/Share	295 Reduced 0.02%	1,454,569 Common Stock
Nov 28 2025	BUY Exercise of conversion of derivative security	-	610 Added 0.04%	1,454,864 Common Stock
Nov 26 2025	SELL Payment of exercise price or tax liability	$17,201 $24.75 p/Share	695 Reduced 0.05%	1,454,254 Common Stock
Nov 26 2025	BUY Exercise of conversion of derivative security	-	1,437 Added 0.1%	1,454,949 Common Stock
Aug 29 2025	SELL Payment of exercise price or tax liability	$7,708 $24.47 p/Share	315 Reduced 0.02%	1,453,512 Common Stock

Aug 29 2025	BUY Exercise of conversion of derivative security	-	651 Added 0.04%	1,453,827 Common Stock
Aug 28 2025	SELL Payment of exercise price or tax liability	$7,429 $25.1 p/Share	296 Reduced 0.02%	1,453,176 Common Stock
Aug 28 2025	BUY Exercise of conversion of derivative security	-	611 Added 0.04%	1,453,472 Common Stock
Aug 27 2025	SELL Payment of exercise price or tax liability	$17,187 $24.73 p/Share	695 Reduced 0.05%	1,452,861 Common Stock
Aug 27 2025	BUY Exercise of conversion of derivative security	-	1,437 Added 0.1%	1,453,556 Common Stock
May 30 2025	SELL Payment of exercise price or tax liability	$8,509 $26.93 p/Share	316 Reduced 0.02%	1,452,119 Common Stock
May 30 2025	BUY Exercise of conversion of derivative security	-	652 Added 0.04%	1,452,435 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$7,894 $26.76 p/Share	295 Reduced 0.02%	1,451,783 Common Stock
May 28 2025	BUY Exercise of conversion of derivative security	-	610 Added 0.04%	1,452,078 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$18,250 $26.26 p/Share	695 Reduced 0.05%	1,451,468 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	-	1,436 Added 0.1%	1,452,163 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$19,027 $31.09 p/Share	612 Reduced 0.04%	1,450,727 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	1,263 Added 0.09%	1,451,023 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$93,318 $33.58 p/Share	2,779 Reduced 0.19%	1,450,076 Common Stock
Feb 27 2025	BUY Exercise of conversion of derivative security	-	5,746 Added 0.39%	1,452,855 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$85,707 $30.93 p/Share	2,771 Reduced 0.19%	1,447,109 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	5,734 Added 0.39%	1,449,880 Common Stock
Feb 07 2025	SELL Payment of exercise price or tax liability	$9,444 $33.61 p/Share	281 Reduced 0.02%	1,444,146 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account